Seeger Weiss Announces $425 Million Settlement with AstraZeneca in Proton-Pump Inhibitor Litigation

Seeger Weiss is pleased to announce a landmark $425 million settlement with AstraZeneca Pharmaceuticals in the Proton-Pump Inhibitor Products Liability Litigation. This significant achievement comes on behalf of thousands of consumers who suffered kidney injuries while using proton-pump inhibitor (“PPI”) medications. Founding partner Chris Seeger serves as co-lead counsel with Stephanie O’Connor of Douglas & […]

October 3, 2023

Seeger Weiss is pleased to announce a landmark $425 million settlement with AstraZeneca Pharmaceuticals in the Proton-Pump Inhibitor Products Liability Litigation. This significant achievement comes on behalf of thousands of consumers who suffered kidney injuries while using proton-pump inhibitor (“PPI”) medications.

Founding partner Chris Seeger serves as co-lead counsel with Stephanie O’Connor of Douglas & London P.C. and spearheaded negotiations with Justin Witkin of Aylstock, Witkin, Kreis & Overholtz PLLC. Compensation for plaintiffs in the litigation now totals $533.5 million, including additional settlements with GlaxoSmithKline, Pfizer, and Procter & Gamble.

“Today’s settlements are a significant victory for the thousands of patients who suffered kidney injuries as a result of using PPI medications,” said Seeger. “These settlements not only ensure victims receive just compensation for their pain and suffering, but also stand as a testament to the importance of holding pharmaceutical companies accountable for failing to warn patients and doctors about the health risks associated with their products.”

In the litigation, plaintiffs alleged that the regular use of PPI medications like Prevacid, Dexilant, Nexium, Prilosec, and Protonix could lead to kidney injuries, including interstitial nephritis, which may progress to chronic kidney disease and end-stage renal disease. Plaintiffs further contended that defendants failed to conduct adequate research and concealed these risks.

The settlement resolves litigation against AstraZeneca for approximately 11,000 plaintiffs with claims in the MDL and various state court jurisdictions. Plaintiffs have yet to reach a settlement with Takeda Pharmaceuticals, the maker of PPI drugs Prevacid and Dexilant, and will continue to pursue claims against the company.

“We strongly urge Takeda to recognize the gravity of the harm caused by their PPI products and to come to the table in good faith as other manufacturers did after years of litigation,” Seeger added. “It is time for them to prioritize patient well-being over profits and take meaningful steps towards accepting accountability for those it harmed.”

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, Pennsylvania, and Massachusetts, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

May 24, 2024
Lawdragon Names Nine Seeger Weiss Partners to 500 Plaintiff Financial Lawyers List

Seeger Weiss is proud to announce that Lawdragon recognized nine partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Jennifer Scullion, Chris Ayers, Ben Barnett, Parvin Aminolroaya, and Steve Daroci — on the 2024 500 Leading Plaintiff Financial Lawyers list. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the […]

Read More
May 13, 2024
Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

Read More
May 9, 2024
Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

Read More